SLS Invest

10/01/13

asa.norman — Fri, 11 Jan 2013 10:07:44 +0000

AdvanDx adds Enterococcal Bacteremia assay to U.S. and E.U. commercial launch of QuickFISH^TM (20 Min. Pathogen ID) Platform

asa.norman — Mon, 01 Oct 2012 07:08:25 +0000

Betinget aftale med Teva om Huntexil

asa.norman — Mon, 06 Aug 2012 09:24:04 +0000

Masimo Enters Noninvasive Multigas Monitoring, including Capnography, with acquisition of PHASEIN

asa.norman — Thu, 03 May 2012 13:46:26 +0000

SLS Invest AB announces its second largest transaction ever in terms of deal value

asa.norman — Thu, 03 May 2012 13:44:46 +0000

Abbott to Acquire Action Pharma´s Investigational Compound, AP214, in Phase 2b Development for Prevention of Acute Kidney Injury

asa.norman — Thu, 15 Mar 2012 11:36:57 +0000

AdvanDx to Unveil QuickFISH™ (20 Min. Pathogen ID) at ECCMID 2012

asa.norman — Wed, 29 Feb 2012 09:38:04 +0000

SLS Invest beslutar om investeringar på 25 miljoner kronor

asa.norman — Mon, 20 Feb 2012 11:27:22 +0000

Doxa lanserar ny produkt: Ceramir Crown & Bridge SingleCap

asa.norman — Wed, 07 Dec 2011 11:22:56 +0000

Gyros expands commercial reach in Asia.

asa.norman — Thu, 13 Oct 2011 14:30:09 +0000

New Study Shows PNA FISH® Test Reporting Dramtically Decreased Mortality and Hospital Costs for Patients with Bloodstream Infections